Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
04/2003
04/02/2003EP1297017A2 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations
04/02/2003EP1297014A2 Transporters and ion channels
04/02/2003EP1297011A1 The t-cell protein tzon7, peptides and antibodies derived therefrom and uses thereof
04/02/2003EP1297007A2 Mammalian protein phosphatases
04/02/2003EP1296996A1 Purine derivatives
04/02/2003EP1296990A2 Dihydropyridine compounds for the inhibition of calcium-influx
04/02/2003EP1296978A2 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity
04/02/2003EP1296976A1 Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them
04/02/2003EP1296975A1 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
04/02/2003EP1296973A1 Guanidine derivatives of quinazoline and quinoline for use in the treatment of autoimmune diseases
04/02/2003EP1296972A1 Arylmethylamine derivatives for use as tryptase inhibitors
04/02/2003EP1296961A1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists
04/02/2003EP1296959A1 Methods and compositions utilizing quinazolinones
04/02/2003EP1296956A1 Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors
04/02/2003EP1296949A2 Piperidine amides as modulators of chemokine receptor activity
04/02/2003EP1296946A1 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof
04/02/2003EP1296943A1 Amino acid derivatives and their use as medicines
04/02/2003EP1296929A2 Modified forms of pharmacologically active agents and uses therefor
04/02/2003EP1296923A2 Aspirin-triggered lipid mediators
04/02/2003EP1296715A2 Multivalent vaccine composition
04/02/2003EP1296713A1 Immunostimulatory oligodeoxynucleotides
04/02/2003EP1296709A1 Solubilised protein vaccines
04/02/2003EP1296702A1 Neuroprotective peptides
04/02/2003EP1296701A1 Use of grifola frondosa fungus extracts
04/02/2003EP1296699A1 Therapeutic agents - iii
04/02/2003EP1296698A1 Therapeutic agents - ii
04/02/2003EP1296697A1 Therapeutic agents - i
04/02/2003EP1296692A1 Use of a formulation made of or containing at least one dissimilated milk serum
04/02/2003EP1296646A2 Oral pharmaceutical compositions containing terbinafine
04/02/2003EP1296644A2 Systems and methods for treating a mucosal surface
04/02/2003EP1226143B1 Imidazopyridine derivatives used as phosphodiesterase vii inhibitors
04/02/2003EP1208100B1 Selective antagonists of a2b adenosine receptors
04/02/2003EP1114051B1 INHIBITORS OF p38
04/02/2003EP1080206B1 Generation of multiple gene products from chimeric fusion proteins by cleavage with endoproteases
04/02/2003EP1030842B1 Metalloproteinase inhibitors
04/02/2003EP0956286B1 Synthesis of terfenadine and derivatives
04/02/2003EP0954519B1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof
04/02/2003EP0951467B1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE
04/02/2003EP0873295B1 Dimer-selective rxr modulators and methods for their use
04/02/2003EP0804236B1 Use of anti-tnf antibodies as drugs in treating diseases involving elevated interleukin-6 serum levels
04/02/2003EP0770081B1 Heterocycle-condensed morphinoid derivatives
04/02/2003EP0763049B1 Nucleoside monophosphate derivatives, a process for their production and their use as immunosuppressive drugs
04/02/2003EP0700444B1 Immunotoxins comprising gelonin and an antibody
04/02/2003EP0675887B1 Antiallergic triazolobenzazepine derivatives
04/02/2003EP0621865B1 Rapamycin derivative and its medicinal use
04/02/2003EP0587800B1 Immunomodulatory azaspiranes
04/02/2003CN1407993A Gene recombinant antibody and its fragment
04/02/2003CN1407985A Heterocyclic dihydropyrimidine as potassium path inhibitor
04/02/2003CN1407968A Adamantane derivatives
04/02/2003CN1407897A DHEA composition and method
04/02/2003CN1406617A Tablets against allergic purpura
04/02/2003CN1406523A Oral liquid production
04/02/2003CN1104501C Modified human C3 proteins
04/02/2003CN1104432C Pyrrole triazines and pyrimidine compound
04/02/2003CN1104256C Cyclosporin soft capsule composition
04/02/2003CN1104255C Water extracting process for high activity glossy ganoderma holoside and high content glossy ganoderma acid
04/02/2003CN1104238C Enteric-coated pharmaceutical compositions of mycophenolate
04/01/2003US6541670 Antiinflammatory agents
04/01/2003US6541638 (2S,4S)-1-(4-Mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carbonyl)-piperidine-4-carboxylic acid ethyl ester for example; zinc protease inhibitors; for treating diseases associated with vasoconstriction
04/01/2003US6541623 Sepsis shock therapy; rheumatic diseases; antiinflammatory agents; nucleotide sequence detector
04/01/2003US6541612 Complex of rapamycin-42 ester with dicarboxylic acid and fluorescein; antibody detection/generation; immunoglobulins; hybridomas; ring opening; precipitation
04/01/2003US6541605 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
04/01/2003US6541523 Methods for treating or preventing fibromyalgia using very low doses of cyclobenzaprine
04/01/2003US6541496 Inhibitors of IMPDH enzyme
04/01/2003US6541490 Treating ischemia or reoxygenation injury; preparation from a bipyridine, a benzeneboronic acid and a manganese salt
04/01/2003US6541486 Used for treating ischemia, such as results from stroke or myocardial infarction, trauma, neurodegeneration, and inflammation.
04/01/2003US6541485 Urea substituted imidazoquinolines
04/01/2003US6541482 Autoimmune disease
04/01/2003US6541474 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia
04/01/2003US6541469 CRF receptor antagonists and methods relating thereto
04/01/2003US6541453 Peptide derivatives
04/01/2003US6541253 Diagnostics and therapy of diseases associated with HHV-8 infections
04/01/2003US6541042 Comprising 5-25% by weight terpinen-4-ol-containing essential oils and 0.01-10% by weight tannin-containing medicinal plants or extracts thereof, used for topical treatment of cutaneous and mucous membrane affections in veterinary sector
04/01/2003US6540999 Administering to patient an antigen, a multivalent conjugate of multiple Lewisx antigen-containing oligosaccharides crosslinked to a carrier molecule and an adjuvant to stimulate a specific antibody response to above antigen
04/01/2003US6540977 Cyanidin compositions and therapeutic and diagnostic uses therefor
03/2003
03/27/2003WO2003029411A2 Novel cyclooxygenase variants and methods of use
03/27/2003WO2003025542A2 Immune response associated proteins
03/27/2003WO2003025199A2 Mid 4460, a human tyrosine phosphatase family member and uses therefor
03/27/2003WO2003025178A1 Novel protein and dna thereof
03/27/2003WO2003025155A1 Fermentation product of cyptoporus volvatus and its preparation method and use
03/27/2003WO2003025151A2 Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression
03/27/2003WO2003025131A2 Protein modification and maintenance molecules
03/27/2003WO2003025129A2 Neurotransmission-associated proteins
03/27/2003WO2003025121A2 Igf-binding protein-derived peptide or small molecule
03/27/2003WO2003025119A2 Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance fc receptor-mediated immunotherapies
03/27/2003WO2003025017A1 Cytokine receptor
03/27/2003WO2003025015A2 A soluble toll-like receptor
03/27/2003WO2003025014A2 Use of peptides comprising post-translational modifications in the treatment of autoimmune pathologies
03/27/2003WO2003025012A2 Therapeutic vaccine peptide complex for preventing and treating disorders in mammals
03/27/2003WO2003025009A1 RECOMBINANT ALLERGEN WITH REDUCED IgE BINDING BUT UNDIMINISHED T-CELL ANTIGENICITY
03/27/2003WO2003025000A2 Peptides capable of modulating immune response
03/27/2003WO2003024993A2 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
03/27/2003WO2003024966A1 Pteridinone derivatives as modulators of chemokine receptor activity
03/27/2003WO2003024962A1 Piperidine derivatives and their use as modulators of chemokine (especially ccr3) activity
03/27/2003WO2003024929A1 Substituted piperidines with selective binding to histamine h3-receptor
03/27/2003WO2003024928A2 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives
03/27/2003WO2003024922A1 Hydroxyfattysulfonic acid analogs
03/27/2003WO2003024913A1 SUBSTITUTED BENZOIC ACID DERIVATIVES EXHIBITING NF-κB INHIBITING ACTIVITY
03/27/2003WO2003024481A2 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
03/27/2003WO2003024479A1 Enamel matrix protein compositions for modulating immune response
1 ... 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 ... 1172